Health Observer Falkland Islands
SEE OTHER BRANDS

Daily news on health and wellness in the Falkland Islands

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on July 29, 2025

Telix H1 2025 Results: Investor Webcast Notification

Telix H1 2025 Results: Investor Webcast Notification

MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025 …

Fuelled by an Oversubscribed Seed Round, pRxEngage Aims to Make Clinical Trials a Real Option for All

Fuelled by an Oversubscribed Seed Round, pRxEngage Aims to Make Clinical Trials a Real Option for All

With 30K+ users in the past month alone, pRxEngage is turning discovery into action, making clinical trial access smarter, more personal, and more human. ATLANTA , GA, UNITED STATES, July 29, 2025 /⁨EINPresswire.com⁩/ -- In less than three months from …

Rakovina Therapeutics Announces Stock Option Grants

Rakovina Therapeutics Announces Stock Option Grants

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug …

Amedisys Reports Second Quarter 2025 Financial Results

Amedisys Reports Second Quarter 2025 Financial Results

BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025. Three-Month Periods Ended June 30, 2025 and 2024 Net service revenue increased $ …

Informations sur le nombre total de droits de vote et d'actions

Informations sur le nombre total de droits de vote et d'actions

INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 29 juillet 2025, 22:45h CET / 16:45h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des …

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), July 29, 2025, 10:45 pm CET / 4:45 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, …

Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025

Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025

Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025 Mont-Saint-Guibert, Belgique – Mardi 29 juillet 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de …

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Canaccord Genuity 45th Annual …

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough …

100th Fisher House Dedicated at Lovell Federal Health Care Center

100th Fisher House Dedicated at Lovell Federal Health Care Center

North Chicago, IL, July 29, 2025 (GLOBE NEWSWIRE) -- A new Fisher House was dedicated at the Captain James A. Lovell Federal Health Care Center (Lovell FHCC) by Lovell FHCC Director Dr. Robert Buckley, Deputy Director, Commanding Officer NMRTC Great Lakes …

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage …

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation

Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique …

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 …

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management will …

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …

Teladoc Health Reports Second Quarter 2025 Results

Teladoc Health Reports Second Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 (“Second Quarter 2025”). Unless otherwise noted, percentage and …

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions